Concepedia
Publication | Open Access
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
300
Citations
19
References
2023
Year
ClinicalTrials.gov Identifier: NCT03745170.
Page 1